FDA clears glaucoma laser device from BELKIN Vision
BELKIN Vision has announced the FDA clearance for its glaucoma laser, the Eagle device. The Eagle, a Q-switched, 532 nm-wavelength, frequency-doubled Nd:YAG laser, is designed for...
Read →Latest Laser Technology coverage for Health decision-makers.
BELKIN Vision has announced the FDA clearance for its glaucoma laser, the Eagle device. The Eagle, a Q-switched, 532 nm-wavelength, frequency-doubled Nd:YAG laser, is designed for...
Read →The laser technology market is expected to reach USD 15.38 billion by 2022, growing at a CAGR of 5.2 percent between 2017 and 2022. Enhanced performance over the traditional materi...
Read →Latest Articles coverage for Health decision-makers.
02Latest Awareness & Orientation coverage for Health decision-makers.
03Latest Campaigns & Recent Studies coverage for Health decision-makers.
04Latest Country Reports coverage for Health decision-makers.
05Latest Diet & Nutrition coverage for Health decision-makers.
06Latest Events coverage for Health decision-makers.
07Latest Features coverage for Health decision-makers.
08Latest Health & Nutrition coverage for Health decision-makers.
09Latest Healthcare Technology coverage for Health decision-makers.
10Latest Hospital & Medical Equipment coverage for Health decision-makers.
11Latest Hospital & Medical Equipment & Supplies coverage for Health decision-makers.
12Latest Latest News coverage for Health decision-makers.
13Latest Medical Equipment coverage for Health decision-makers.
14Latest Neurology coverage for Health decision-makers.
15Latest Opinion & Interviews coverage for Health decision-makers.
16Latest Pharmaceuticals coverage for Health decision-makers.
17Latest Product Focus coverage for Health decision-makers.
18Latest Specialities coverage for Health decision-makers.
19Latest Top 5 coverage for Health decision-makers.
20Latest Urology coverage for Health decision-makers.
21Latest Wearable Fitness Technology coverage for Health decision-makers.